Ys Biopharma Co Stock Buy Hold or Sell Recommendation

YS Stock   1.02  0.11  12.09%   
Allowing for the 90-day total investment horizon and your typical level of risk aversion, our recommendation regarding YS Biopharma Co is 'Strong Sell'. Macroaxis provides YS Biopharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding YS positions. The advice algorithm takes into account all of YS Biopharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting YS Biopharma's buy or sell advice are summarized below:
Real Value
0.74
Target Price
5.1
Hype Value
1.02
Market Value
1.02
Naive Value
1.02
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell YS Biopharma Co given historical horizon and risk tolerance towards YS Biopharma. When Macroaxis issues a 'buy' or 'sell' recommendation for YS Biopharma Co, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out YS Biopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as YS Biopharma and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards YS Biopharma Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Execute YS Biopharma Buy or Sell Advice

The YS Biopharma recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on YS Biopharma Co. Macroaxis does not own or have any residual interests in YS Biopharma Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute YS Biopharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell YS BiopharmaBuy YS Biopharma
Strong Sell

Market Performance

SolidDetails

Volatility

Out of controlDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

AverageDetails

Economic Sensitivity

Moves totally opposite to the marketDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Strong BuyDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon YS Biopharma Co has a Mean Deviation of 5.12, Semi Deviation of 4.44, Standard Deviation of 7.25, Variance of 52.61, Downside Variance of 33.51 and Semi Variance of 19.76
We provide trade recommendation to complement the latest expert consensus on YS Biopharma Co. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at this time. To make sure YS Biopharma is not overpriced, please check out all YS Biopharma Co fundamentals, including its price to sales, cash flow from operations, and the relationship between the shares owned by institutions and net income . Given that YS Biopharma is a hitting penny stock territory we urge to closely look at its shares owned by insiders.

YS Biopharma Trading Alerts and Improvement Suggestions

YS Biopharma is way too risky over 90 days horizon
YS Biopharma has some characteristics of a very speculative penny stock
YS Biopharma appears to be risky and price may revert if volatility continues
YS Biopharma has high likelihood to experience some financial distress in the next 2 years
The company generated the yearly revenue of 687.2 M. Annual Net Loss to common stockholders was (145.48 M) with gross profit of 0.
YS Biopharma generates negative cash flow from operations
About 81.0% of the company outstanding shares are owned by insiders
Latest headline from seekingalpha.com: YS Biopharma to change legal name to LakeShore Biopharma

YS Biopharma current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. YS Biopharma analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. YS Biopharma analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

YS Biopharma Returns Distribution Density

The distribution of YS Biopharma's historical returns is an attempt to chart the uncertainty of YS Biopharma's future price movements. The chart of the probability distribution of YS Biopharma daily returns describes the distribution of returns around its average expected value. We use YS Biopharma Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of YS Biopharma returns is essential to provide solid investment advice for YS Biopharma.
Mean Return
1.63
Value At Risk
-8.51
Potential Upside
12.70
Standard Deviation
7.25
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of YS Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

YS Biopharma Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to YS Biopharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that YS Biopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a YS Biopharma stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
1.56
β
Beta against NYSE Composite1.57
σ
Overall volatility
7.33
Ir
Information ratio 0.22

YS Biopharma Volatility Alert

YS Biopharma Co is displaying above-average volatility over the selected time horizon. YS Biopharma Co is a potential penny stock. Although YS Biopharma may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in YS Biopharma Co. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on YS Biopharma instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

YS Biopharma Fundamentals Vs Peers

Comparing YS Biopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze YS Biopharma's direct or indirect competition across all of the common fundamentals between YS Biopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as YS Biopharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of YS Biopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing YS Biopharma by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare YS Biopharma to competition
FundamentalsYS BiopharmaPeer Average
Return On Equity-0.78-0.31
Return On Asset-0.1-0.14
Profit Margin(0.67) %(1.27) %
Operating Margin(0.49) %(5.51) %
Current Valuation430.4 M16.62 B
Shares Outstanding188.33 M571.82 M
Shares Owned By Insiders81.42 %10.09 %
Shares Owned By Institutions2.85 %39.21 %
Number Of Shares Shorted38.89 K4.71 M
Price To Book2.10 X9.51 X
Price To Sales0.29 X11.42 X
Revenue687.2 M9.43 B
EBITDA(76.82 M)3.9 B
Net Income(145.48 M)570.98 M
Total Debt498.63 M5.32 B
Book Value Per Share5.10 X1.93 K
Cash Flow From Operations(182.47 M)971.22 M
Short Ratio0.35 X4.00 X
Earnings Per Share(0.57) X3.12 X
Target Price4.25
Number Of Employees77318.84 K
Beta0.54-0.15
Market Capitalization192.09 M19.03 B
Total Asset1.72 B29.47 B
Retained Earnings(1.87 B)9.33 B
Working Capital377.22 M1.48 B
Net Asset1.72 B

YS Biopharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as YS Biopharma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About YS Biopharma Buy or Sell Advice

When is the right time to buy or sell YS Biopharma Co? Buying financial instruments such as YS Biopharma Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total380.6M498.6M573.4M329.1M
Total Assets1.4B1.7B2.0B1.6B

Use Investing Ideas to Build Portfolios

In addition to having YS Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Financials ETFs Thematic Idea Now

Financials ETFs
Financials ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether YS Biopharma is a strong investment it is important to analyze YS Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact YS Biopharma's future performance. For an informed investment choice regarding YS Biopharma Stock, refer to the following important reports:
Check out YS Biopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for YS Biopharma Stock analysis

When running YS Biopharma's price analysis, check to measure YS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy YS Biopharma is operating at the current time. Most of YS Biopharma's value examination focuses on studying past and present price action to predict the probability of YS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move YS Biopharma's price. Additionally, you may evaluate how the addition of YS Biopharma to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is YS Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of YS Biopharma. If investors know YS Biopharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about YS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
9.461
Earnings Share
(0.57)
Revenue Per Share
4.67
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.10)
The market value of YS Biopharma is measured differently than its book value, which is the value of YS Biopharma that is recorded on the company's balance sheet. Investors also form their own opinion of YS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is YS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because YS Biopharma's market value can be influenced by many factors that don't directly affect YS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between YS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if YS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, YS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.